Search

everythinglearnresearchcommunity

for

Search:↓

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

Insulin resistance is found in 20% of Thai women with PCOS, with age, waist size, skin changes, and abnormal blood fats increasing the risk.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Young women with PCOS and no other heart risk factors have normal heart function.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Metformin improved insulin resistance and BMI in overweight Taiwanese women with PCOS, and a 2-hour insulin test may be a good screening tool.

Insulin resistance is linked to larger thyroid volume in patients with polycystic ovary syndrome.